HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways-Reference-Cited by-同舟云学术

HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways

Published:2010-12-19 Issue:2 Volume:102 Page:393-399
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Nakabayashi Hiromichi,Shimizu Keiji

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01794.x/fullpdf

Reference41 articles.

1. Rho GTPases and the actin cytoskeleton;Hall;Science,1998

2. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension;Uehata;Nature,1997

3. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells;Kaibuchi;Annu Rev Biochem,1999

4. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets;Klages;J Cell Biol,1999

5. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity;Billadeau;J Exp Med,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate;Frontiers in Genetics;2022-05-17

2. DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia;Cancers;2021-09-29

3. RhoA/ROCK signaling pathway and astrocytes in ischemic stroke;Metabolic Brain Disease;2021-03-20

4. Rho kinase inhibitor fasudil reduces l ‐DOPA‐induced dyskinesia in a rat model of Parkinson's disease;British Journal of Pharmacology;2020-11-03

5. Should we keep rocking? Portraits from targeting Rho kinases in cancer;Pharmacological Research;2020-10